HHS committee aims to limit FDA oversight of HIT products

08/13/2013 | BeckersHospitalReview.com

Health IT products, with some exceptions, should not be subject to FDA premarket requirements, according to an HHS workgroup asked to create a strategy for these products that would promote innovation while also ensuring patient safety. The workgroup did note that medical device accessories and some high-risk solutions should fall under FDA review. It also recommended post-market safety testing and a public reporting process for HIT products.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT